BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 402772)

  • 1. Circulating anticoagulant against Factor XII and platelet antibodies in systemic lupus erythematosus.
    Gandolfo GM; Afeltra A; Amoroso A; Biancolella F; Ferri GM
    Acta Haematol; 1977; 57(3):135-42. PubMed ID: 402772
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating anticoagulant against factors XI and XII together with massive spontaneous platelet aggregation.
    Cronberg S; Nilsson IM
    Scand J Haematol; 1973; 10(4):309-14. PubMed ID: 4587560
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating anticoagulants.
    Green D
    Med Clin North Am; 1972 Jan; 56(1):145-51. PubMed ID: 4550288
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients.
    Regan MG; Lackner H; Karpatkin S
    Ann Intern Med; 1974 Oct; 81(4):462-8. PubMed ID: 4213298
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating anticoagulant against factor XI and thrombocytopenia with platelet aggregation inhibition in systemic lupus erythematosus.
    Leone G; Accorra F; Boni P
    Acta Haematol; 1977; 58(4):240-5. PubMed ID: 410226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circulating anticoagulant directed against factor XIa in systemic lupus erythematosus.
    DiSabatino CA; Clyne LP; Malawista SE
    Arthritis Rheum; 1979 Oct; 22(10):1135-8. PubMed ID: 486223
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cryofibrinogenemia, hemophilic syndrome caused by circulating anticoagulants and autohemagglutinins in systemic lupus erythematosus].
    Trotta F; Castaldi G; Ballerini G
    Reumatismo; 1972; 24(2):180-2. PubMed ID: 4681344
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic lupus erythematosus and spontaneously arising anticoagulants.
    Jacobs P; Bracher M; Meyers OL
    S Afr Med J; 1975 Oct; 49(45):1881-2. PubMed ID: 1188558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The coagulation abnormalities in systemic lupus erythematosus.
    Gonyea L; Herdman R; Bridges RA
    Thromb Diath Haemorrh; 1968 Dec; 20(3):457-64. PubMed ID: 4179647
    [No Abstract]   [Full Text] [Related]  

  • 10. [Presence of circulating anticoagulants in a patient with systemic lupus erythematosus].
    Porro T; Amante L; Sideri G; Eridani S
    Resen Clin Cient; 1970; 39(7):179-86. PubMed ID: 5493733
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to factor XII: a possible predictive marker for recurrent foetal loss.
    Jones DW; Gallimore MJ; Winter M
    Immunobiology; 2003; 207(1):43-6. PubMed ID: 12638902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.
    Castro O; Farber LR; Clyne LP
    Ann Intern Med; 1972 Oct; 77(4):543-8. PubMed ID: 4642734
    [No Abstract]   [Full Text] [Related]  

  • 13. Disorders of hemostatic function in patients with systemic lupus erythematosus.
    Lee SL; Miotti AB
    Semin Arthritis Rheum; 1975 Feb; 4(3):241-52. PubMed ID: 1091975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus with anticardiolipin antibodies and lupus anticoagulant syndrome.
    Jawad AS; Berry H
    J R Soc Med; 1985 Aug; 78(8):677-8. PubMed ID: 4020804
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII.
    Aberg H; Nilsson IM
    Acta Med Scand; 1972 Nov; 192(5):419-25. PubMed ID: 5083382
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating anticoagulant in disseminated lupus erythematosus. Proposed mode of action.
    Veltkamp JJ; Kerkhoven P; Loeliger EA
    Haemostasis; 1973-1974; 2(6):253-9. PubMed ID: 4137579
    [No Abstract]   [Full Text] [Related]  

  • 17. Naturally occurring anticoagulants: a case report.
    Ross SA
    N Z Med J; 1968 Mar; 67(430):411-3. PubMed ID: 4968117
    [No Abstract]   [Full Text] [Related]  

  • 18. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XII deficiency with systemic lupus erythematosus. Biological implications.
    Passero FC; Myers AR; Guerry D
    Arthritis Rheum; 1979 Apr; 22(4):419-22. PubMed ID: 426885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-factor XI circulating anticoagulant (author's transl)].
    Durán Suárez JR; Vilaseca J; Ordeig J; Triginer J
    Sangre (Barc); 1981; 26(5-A):631-7. PubMed ID: 7323919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.